Download Files:
PCSK9-IN-16
SKU
HY-153452-Get quote
Category Reference compound
Tags Cardiovascular Disease, Metabolic Enzyme/Protease, Ser/Thr Protease
Products Details
Product Description
– PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potential for hypercholesterolemia and other cardiovascular diseases research[1].
Web ID
– HY-153452
Shipping
– Room temperature
Molecular Formula
– C16H20N6O2S3
References
– [1]Michael H, et al. Pcsk9 inhibitors and methods of use thereof. Patent WO2020150474
CAS Number
– 2455424-51-6
Molecular Weight
– 424.56
SMILES
– CSC1=CN=C(N=C1)NC[C@H](C)CNC(SC2=C3)=NC2=CC=C3S(N)(=O)=O
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Ser/Thr Protease
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.